Article Details

Gennova's mRNA-based COVID-19 vaccine gets approval for Phase 2/3 clinical trials - The Hindu

Retrieved on: 2021-08-24 11:48:45

Tags for this article:

Click the tags to see associated articles and topics

Gennova's mRNA-based COVID-19 vaccine gets approval for Phase 2/3 clinical trials - The Hindu. View article details on hiswai:

Excerpt

India's first mRNA-based COVID-19 vaccine candidate HGCO19 by Gennova Biopharmaceuticals Ltd has been granted approval for Phase 2/3 clinical trails, ...

Article found on: www.thehindu.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up